AGP Executive Report
Last update: 2 hours agoVaccine Watch: Valneva reported €64.0M in first-half 2026 product sales, reaffirming full-year guidance of €135–150M, with regulatory decisions for its Lyme disease vaccine candidate expected within the next year. Climate & Health: A new look at urban heat islands warns tropical cities often can’t fund fixes like shade, green roofs, cooler surfaces, and better airflow—risking worse outcomes as El Niño strengthens. Food & Gut Science: A review links ultraprocessed-food additives to gut microbiome disruption and a weaker intestinal barrier, pointing to dysbiosis and inflammation pathways. Public Health Policy: In New Orleans, officials say a Trump executive order on childhood vaccines doesn’t change current school requirements, even as it shifts the recommended disease list and how shots may be scheduled. Transport & Infrastructure: France’s Grand Paris Express update highlights progress on automated metro lines and 68 architect-designed stations, with testing and station-by-station delivery continuing through 2031. Local Emergency Care (Mauritius): A tribute piece spotlights SAMU’s evolution and the push for coordinated pre-hospital emergency response. Migration: Reports on Channel crossings note a large dinghy incident even as overall numbers remain down, keeping pressure on UK small-boat policy.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
